Author Correction: Decade-long leukaemia remissions with persistence of CD4⁺ CAR T cells

Affiliations

• ¹ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.
• ² Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.
• ³ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.
• ⁴ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.
• ⁵ Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA. mej@pennmedicine.upenn.edu.
• ⁶ Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, PA, USA.
• ⁷ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁸ Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁰ Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹¹ Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
• ¹² Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
• ¹³ Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁴ Novartis Institute for Biomedical Research, Cambridge, MA, USA.
• ¹⁵ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁶ Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁷ Department of Transfusion Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁸ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁹ Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA.
• ²⁰ Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ²¹ Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.
• ²² Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.
• ²³ Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.
• ²⁴ Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. tank1@chop.edu.
• ²⁵ Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.
• ²⁶ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
• ²⁷ Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
• ²⁸ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
• ²⁹ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
• ³⁰ Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA. cjune@upenn.edu.